A vaccine expert breaks down everything you need to know about the Novavax vaccine.
Good news for children and young people, bad news for Johnson & Johnson.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
With four COVID-19 vaccines approved for use in Canada, it's time to answer FAQs about efficacy, immunity, eradication and variants.
Australia should pivot to a high-efficacy vaccine like Pfizer or Novavax to give us the best chance of achieving herd immunity.
Vaccine developers pledge to create boosters that can better handle the new variants of the virus, and new data gives reassurance on the Oxford vaccine.
Both vaccines appear to reduce the risk of developing COVID-19, and so could be approved later this year.
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It's based on a vaccine that was already in development for influenza, and has shown promise in animal studies.